You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AHSCT

Showing 1 - 25 of 77
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • pegylated recombinant human granulocyte-colony stimulating factor
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Sep 23, 2023

Multiple Sclerosis Trial in Saint Petersburg (Fludarabine Phosphate for Injection)

Recruiting
  • Multiple Sclerosis
  • Fludarabine Phosphate for Injection
  • Saint Petersburg, Russian Federation
    First Pavlov State Medical University of St. Petersburg
Apr 14, 2023

Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

Recruiting
  • Multiple Myeloma
  • BCMA CAR-T cells injection
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Feb 13, 2023

Lymphoma Trial (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • filgrastim
  • +4 more
  • (no location specified)
Jun 16, 2021

Relapsing-Remitting Multiple Sclerosis Trial in Hamburg, Mannheim (Autologous Hematopoietic Stem Cell Transplantation,

Terminated
  • Relapsing-Remitting Multiple Sclerosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Hamburg, Germany
  • +1 more
Mar 1, 2022

Multiple Myeloma Trial in Atlanta, Chicago (procedure, drug, other)

Recruiting
  • Multiple Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Atlanta, Georgia
  • +1 more
Feb 25, 2022

MDS, AML Trial in France (venetoclax + azacitidine +/- donor lymphocyte infusion)

Not yet recruiting
  • MDS
  • AML
  • venetoclax + azacitidine +/- donor lymphocyte infusion
  • Amiens, France
  • +13 more
Jul 21, 2022

Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

Active, not recruiting
  • Plasma Cell Myeloma
  • Omaha, Nebraska
    University of Nebraska Medical Center
Nov 21, 2022

REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS Trial in Paris Cedex 10 (Autologous Hematopoietic Stem Cell Transplantation, Rituximab)

Withdrawn
  • REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
  • Autologous Hematopoietic Stem Cell Transplantation
  • Rituximab
  • Paris Cedex 10, France
    Dept. of Internal Medicine, Hôpital Saint-Louis
Sep 21, 2021

Plasma Cell Myeloma Trial in Jacksonville (procedure, biological, drug)

Active, not recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 25, 2022

Type 1 Diabetes Trial in Shanghai (AHSCT, Insulin therapy)

Completed
  • Type 1 Diabetes Mellitus
  • AHSCT
  • Insulin therapy
  • Shanghai, Shanghai, China
    Shanghai Jiao Tong University School of Medicine
Nov 16, 2021

Multiple Sclerosis Patients Treated With Autologous

Not yet recruiting
  • Multiple Sclerosis
  • aHSCT
  • (no location specified)
Dec 17, 2020

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

Active, not recruiting
  • Plasma Cell Leukemia
  • +3 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 6, 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

    Not yet recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +2 more
    • Orange, California
      Chao Family Comprehensive Cancer Center, University of Californi
    Aug 31, 2023

    Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma Trial (procedure, drug, biological, radiation, other)

    Not yet recruiting
    • Recurrent Classic Hodgkin Lymphoma
    • Refractory Classic Hodgkin Lymphoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +13 more
    • (no location specified)
    Feb 2, 2023

    Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

    Withdrawn
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +9 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +5 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Plasma Cell Myeloma Trial in Houston (procedure, biological, drug)

    Recruiting
    • Plasma Cell Myeloma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 23, 2020

    AL Amyloidosis Trial (procedure, drug, other)

    Not yet recruiting
    • AL Amyloidosis
    • Autologous Hematopoietic Stem Cell Transplantation
    • +15 more
    • (no location specified)
    Aug 28, 2023

    Hematopoietic Stem Cell Transplantation for Treatment of

    Recruiting
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • Autologous hematopoietic stem cell transplantation
    • Gothenburg, Sweden
    • +7 more
    Feb 7, 2022

    EBMT ADWP Prospective Non-interventional Study: Post-AHSCT

    Recruiting
    • Autoimmune Diseases
    • Autologous HSCT
    • Paris, France
      Badoglio Manuela- EBMT Paris Office
    Aug 29, 2019

    Acute Myeloid Leukemia Trial in Worldwide (Sabatolimab, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • Marseille, France
    • +11 more
    Mar 29, 2022

    Ganglioneuroblastoma, High Risk Neuroblastoma Trial in Australia, New Zealand, United States (procedure, drug, biological,

    Active, not recruiting
    • Ganglioneuroblastoma
    • High Risk Neuroblastoma
    • Autologous Hematopoietic Stem Cell Transplantation
    • +14 more
    • Los Angeles, California
    • +9 more
    Sep 1, 2022

    High-risk Diffuse Large B-cell Lymphoma Trial in Worldwide (Blinatumomab)

    Terminated
    Has Results
    • High-risk Diffuse Large B-cell Lymphoma
    • Atlanta, Georgia
    • +31 more
    Sep 10, 2020